Combining virtual screening with cis-/trans-cleavage enzymatic assays effectively reveals broad-spectrum inhibitors that target the main proteases of SARS-CoV-2 and MERS-CoV
- Resource Type
- Article
- Source
- In
Antiviral Research August 2023 216 - Subject
- Language
- ISSN
- 0166-3542